Synairgen is a biotechnology company that focuses on developing innovative therapies for patients with respiratory diseases, particularly targeting antiviral treatments for severe respiratory infections. Their research centers on harnessing the power of the immune system to create effective medicines for conditions such as asthma and COVID-19.